Commonwealth Coat of Arms of Australia

 

 

 

 

 

 

PB 62 of 2025

 

National Health (Originator Brand) Amendment Determination (No. 4) 2025

 I, Rebecca Richardson, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make the following Determination.

Dated          29        May 2025  

REBECCA RICHARDSON

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health, Disability and Ageing


1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

 

 

  This instrument is the National Health (Originator Brand) Amendment Determination (No. 4) 2025.

  This instrument may also be cited as PB 62 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

 1 June 2025

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 99ADB(6B) of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

1  Schedule 1, (after table item 61)

 

Insert:

 

61A

Dienogest

Visanne

 

 

 

2  Schedule 1, (after table item 176)

 

Repeal:

 

177

Oxycodone

Endone

OxyNorm

OxyContin

Oral

 

 

 

Proladone

Rectal

 

177A

Paclitaxel, nanoparticle albumin-bound

Abraxane

 

 

177B

Palonosetron

Aloxi

 

 

 

 

 

 

 

Substitute:

 

177

Oxycodone

Endone

OxyNorm

OxyContin

Oral

 

 

 

Proladone

Rectal

 

177A

Oxycodone with naloxone

Targin 2.5/1.25 mg

Targin 5/2.5mg

Targin 10/5mg

Targin 15/7.5mg

Targin 20/10mg

Targin 30/15 mg

Targin 40/20mg

Targin 60/30

Targin 80/40

 

 

177B

Paclitaxel, nanoparticle albumin-bound

Abraxane

 

 

177C

Palonosetron

Aloxi

 

 

 

3  Schedule 1, (after table item 198)

 

Repeal:

 

199

Ranitidine

Zantac

 

 

 

 

 

 

 

Substitute:

 

199

Ranitidine

Zantac

Zantac 150

Zantac 300